| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785983 | Clinical Oncology | 2018 | 7 Pages |
Abstract
The pilot study showed the feasibility of randomisation between treatment with IGRT alone versus IGRTÂ +Â HDR boost. Treatment compliance was good, including adherence to quality assurance standards.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
E. Vigneault, G. Morton, W.R. Parulekar, T.M. Niazi, C.W. Springer, M. Barkati, P. Chung, W. Koll, A. Kamran, M. Monreal, K. Ding, A. Loblaw,